Data gathered: September 17
Alternative Data for Arrowhead Pharmaceuticals
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 59 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 29,000 | Sign up | Sign up | Sign up |
| Employee Rating | 74 | Sign up | Sign up | Sign up |
| Google Trends | 14 | Sign up | Sign up | Sign up |
| Patents | 93 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 53 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 12,034 | Sign up | Sign up | Sign up |
| Twitter Followers | 3,706 | Sign up | Sign up | Sign up |
| Twitter Mentions | N/A | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 57 | Sign up | Sign up | Sign up |
| Linkedin Employees | 627 | Sign up | Sign up | Sign up |
About Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States.
| Price | $29.13 |
| Target Price | Sign up |
| Volume | 1,840,000 |
| Market Cap | $4.07B |
| Year Range | $9.99 - $29.72 |
| Dividend Yield | 0% |
| Analyst Rating | 60% buy |
| Industry | Biotechnology |
In the news
 |
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Acquires 2,774,933 Shares of Arrowhead Pharmaceuticals, Inc. $ARWRSeptember 15 - ETF Daily News |
|
Dynamic Technology Lab Private Ltd Grows Stake in Arrowhead Pharmaceuticals, Inc. $ARWRSeptember 13 - ETF Daily News |
|
Arrowhead Pharmaceuticals, Inc. $ARWR Shares Sold by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.September 13 - ETF Daily News |
|
ARWR FY2025 EPS Forecast Lowered by Cantor FitzgeraldSeptember 12 - ETF Daily News |
 |
Arrowhead Pharmaceuticals Files Complaint for Declaratory Judgment Against Ionis PharmaceuticalsSeptember 10 - Yahoo |
 |
Arrowhead Pharmaceuticals, Inc. (ARWR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 10 - SeekingAlpha |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '25 | 28M | 6.2M | 22M | -175M | -166M | -1.260 |
| Q1 '25 | 543M | 6.1M | 543M | 370M | 397M | 2.750 |
| Q4 '24 | 2.5M | 5.2M | 2.5M | -173M | -148M | -1.390 |
| Q3 '24 | 24M | 14M | 10M | -171M | -153M | -1.370 |
| Q2 '24 | 0 | 4.8M | -4.8M | -171M | -164M | -1.380 |
Insider Transactions View All
| Hamilton James C filed to sell 232,122 shares at $30. September 16 '25 |
| Hamilton James C filed to sell 247,122 shares at $25. September 4 '25 |
| Hamilton James C filed to sell 262,122 shares at $20. August 15 '25 |
| Hamilton James C filed to sell 271,511 shares at $20. August 15 '25 |
| Anzalone Christopher Richard filed to sell 3,921,255 shares at $11.5. April 11 '25 |
Similar companies
Read more about Arrowhead Pharmaceuticals (ARWR) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Arrowhead Pharmaceuticals?
The Market Cap of Arrowhead Pharmaceuticals is $4.07B.
What is the current stock price of Arrowhead Pharmaceuticals?
Currently, the price of one share of Arrowhead Pharmaceuticals stock is $29.13.
How can I analyze the ARWR stock price chart for investment decisions?
The ARWR stock price chart above provides a comprehensive visual representation of Arrowhead Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Arrowhead Pharmaceuticals shares. Our platform offers an up-to-date ARWR stock price chart, along with technical data analysis and alternative data insights.
Does ARWR offer dividends to its shareholders?
As of our latest update, Arrowhead Pharmaceuticals (ARWR) does not offer dividends to its shareholders. Investors interested in Arrowhead Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Arrowhead Pharmaceuticals?
Some of the similar stocks of Arrowhead Pharmaceuticals are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.